Compound heating strategy: After the surgery begins, a temperature monitoring device (disposable medical temperature sensor provided by the limited company) is inserted into the patient's nasopharynx to record the core temperature, while activating the water blanket and forced air heating system.
The composite warming strategy has a certain effect on preventing hypothermia during cancer liver resection surgery. This study aims to explore the application of compound warming strategy in perioperative nursing of cancer liver resection.
This study will compare two groups: the control group using perioperative forced warming measures, and the experimental group using a composite warming strategy.
Main objective: Intraoperative temperature changes Secondary objective: incidence of complications The investigators' investigated the practicality and effectiveness of a combined warming strategy in open liver resection surgery. In addition, the investigators also conducted a quantitative correlation study on the incidence of hypothermia during the surgical process. This provides evidence-based guidance for the prevention of hypothermia during surgery.
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Aged between 18 and 75 years.
* Scheduled for elective open hepatectomy to treat hepatocellular carcinoma, confirmed by preoperative biopsy or imaging.
* Adequate liver function (Child-Pugh score A or B).
* American Society of Anesthesiologists (ASA) physical status classification of I, II, or well-controlled III.
* Informed consent provided for participation.
Exclusion Criteria:
* Aged under 18 or over 75 years.
* Metastatic liver disease or emergency liver surgery required.
* Chronic analgesic use that could interfere with pain assessment.
* Participation in another clinical trial within the past 30 days.
* Contraindications to warming devices (e.g., certain skin conditions or advanced peripheral vascular disease).
* Pregnant or lactating.
* Presence of an implantable device (e.g., pacemakers or defibrillators) that could be affected by warming strategies.
* Cognitive impairment or psychiatric disorders affecting study understanding or informed consent.
* Use of medications/substances impacting thermoregulation (e.g., illicit drugs, alcohol abuse, antipyretics).
* History of malignancies other than liver cancer affecting survival or perioperative risk.
* Recent history (within six months) of myocardial infarction or cerebrovascular accident.
* Uncontrolled diabetes mellitus or other significant endocrine disorders.
* Severe anemia (hemoglobin below a predetermined threshold).
Primary outcome measure(s)
Intraoperative temperature changes — At the beginning of the surgery; every 5 minutes during surgery; after the surgery is completed. Intraoperative temperature changes: After the surgery begins, a temperature monitoring device (disposable medical temperature sensor provided by the limited company) is inserted into the patient's nasopharynx to record the core temperature, while activating the water blanket and forced air.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.